Atlas Trials

R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL:a Multicenter Phase Ib/II Stuty

Clinical trial NCT04120350 · UNKNOWN

Trial details

NCT number
NCT04120350
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2019-08-16
Primary completion
2022-08-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.